FIELD: medicine.
SUBSTANCE: invention relates to a method for obtaining a pharmaceutical substance xenon hydrate, obtained by holding distilled water for 15 days under xenon gas pressure from 0.4 to 10 MPa and at temperatures above 0°C to obtain a solid fraction, which is a clathrate compound consisting of water and xenon (Xe⋅6H2O), which contains up to 200 volume units of xenon gas per 1 volume of water.
EFFECT: invention provides for the production of a xenon hydrate pharmaceutical substance for the production of a medicinal product.
1 cl, 1 ex, 1 tbl
Title | Year | Author | Number |
---|---|---|---|
METHOD OF INTRODUCING XENON INTO THE HUMAN BODY DURING XENON THERAPY | 2018 |
|
RU2706424C1 |
METHOD FOR PREPARING FINELY DIVIDED IBUPROFEN | 2012 |
|
RU2491919C1 |
METHOD FOR PREPARING FINE PHARMACEUTICAL COMPOSITIONS OF SALBUTAMOL | 2012 |
|
RU2504370C1 |
HIGHLY DISPERSED COMBINED PHARMACEUTICAL COMPOSITION OF METHAZONE AND SALBUTAMOL WITH BETA-GLYCINE AND METHOD OF OBTAINING THEREOF | 2013 |
|
RU2539374C1 |
METHOD OF DETERMINING CONTENT OF PORE WATER IN EQUILIBRIUM WITH GAS HYDRATE IN DISPERSION MEDIA (VERSIONS) | 2008 |
|
RU2391650C1 |
METHOD OF PRODUCING CLATHRATE HYDRATES FOR STORAGE AND TRANSPORTATION OF GASES | 2019 |
|
RU2704971C1 |
AGENT FOR INCREASING BODY EFFICIENCY ON THE BASIS OF α-CYCLODEXTRIN AND USE THEREOF | 2018 |
|
RU2704024C1 |
METHOD OF OBTAINING HIGHLY-DISPERSIVE PARACETAMOL | 2010 |
|
RU2449777C1 |
METHOD FOR CORRECTION OF HUMAN FUNCTIONAL STATE IN CONFINED SPACE | 2018 |
|
RU2712804C1 |
HIGHLY DISPERSIVE PHARMACEUTICAL COMPOSITION OF BUDESONIDE WITH BETA-GLYCINE AND METHOD OF OBTAINING THEREOF | 2013 |
|
RU2539376C1 |
Authors
Dates
2023-04-24—Published
2022-02-28—Filed